Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer

Fig. 2

Added value of the TICS for prognostication in prostate cancer. A The distribution of the TICS in each clinicopathological subgroup and the correlation of the TICS with patients’ age/PSA level. B Subgroup analysis of the prognostic efficacy of the TICS. C Prognostic effect of the TICS in univariable and multivariable models. D The calibration curves of prognostic models with/without the TICS. E The time-dependent AUC of prognostic models with/without the TICS. (PSA prostate specific antigen, HR hazard ratio, BCRFS biochemical recurrence-free survival, CI confidence interval, TCGA The Cancer Genome Atlas, AUC area under the curve.)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us